Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches04 Jan 2011
London – “The nano-enabled drug delivery market has seen high growth in the market and is expected to grow at a faster rate in the near future. The market will witness increased competition, high investment from venture capitalists and government. The M&A and licensing landscape will see significant changes in the future. This is because the market is expected to become more lucrative.”
The report “Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential” by GBI Research provides key data, information and analysis of the major trends and issues in Nanotechnology in Drug Delivery market. The report provides a comprehensive insight into the role of Nanotechnology in Drug Delivery. The report also provides a detailed analysis of market characterization of nanotechnology in drug delivery market in terms of its market size, segmentation by key geography types and the major market drivers and barriers. The report also talks about the technological trends over the years in use of nanotechnology in drug delivery.
The Nano-Enabled Market Represents Significant Opportunities and High Level of Unmet Needs
The nano-enabled drug delivery market has plenty of opportunities and a high level of unmet need. Opportunities for creating a new drug delivery company are tremendous. Many small companies have launched the technology to develop novel methods for exploiting nanotechnologies in drug delivery. In the past, companies have been dedicated to the nano-enabled drug delivery that has been popping up all over the world.
Published: December 2010
Price: USD 3,500
Report Sample Abstract:
The creation of new companies will not only increase the investment and market growth, but also increase the competition in the market place. In addition, the emergence of new companies will provide licensing and merger and acquisition (M&A) opportunities for larger pharmaceutical markets.
The market is also characterized by high levels of unmet need. This is primarily because development in this area is in its initial stages and has a significant number of unaddressed issues such as nanotoxicity, biological behavior and distribution pattern of nanoparticles. These unmet needs represent a significant opportunity for companies to explore.
In summary, high growth in the nano-enabled drug delivery markets will provide significant opportunities for companies.
Increased Investment and Emerging Business Models Will Support the Market Growth
The increasing investment in the nano-enabled drug delivery market has significantly driven the market. Funding for nanotechnology programs increased during the administration of George Bush.
The nanotechnology funding is expected to increase significantly in the future. Among all the major geographies, the European government is investing more in nanotechnology R&D. This suggests that there will be increased governmental support for nanotechnology R&D. In addition, increase in early stage venture capital will also affect the market positively.
Careful Approach of Regulator towards Nanotechnology is Negatively Affecting the Market
The toxicity increases due to increased surface area for the particle when the size is reduced. This gives rise to concerns about the possible negative impact on public health and environment due to increased use of nanotechnology enabled products. Nanotechnology is increasingly being employed in industries such as medicine, cosmetics, food, semiconductor devices, energy and telecommunications due to the advantages it provides over the conventional technology. As the use of nanotechnology progresses, the risk of exposure to the population also rises. This has led a cautious approach of regulators toward nanotechnology.
More information can be found in the report “Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential” by GBI Research.
To order the report or ask for sample pages contact email@example.com